Key Takeaways
- The Spanish health ministry has published a preliminary version of a bill that aims to improve access to medicines and the sustainability of the national health system.
- The wide ranging bill includes an unpopular measure to adjust the reference pricing system to require manufacturers of substitutable medicines to submit prices to authorities every six months.
- Industry groups say the move would jeopardize the supply of medicines.
Provisions in Spain for reforming reference pricing in a draft law aimed at speeding up access to innovative medicines and improving the sustainability of the country’s National Health System (SNS)...
The associations are calling on the government to re-think the so-called “selected prices system” that would exacerbate already difficult conditions for the industry at a time of huge geopolitical instability....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?